Mutations in the FGFR3 gene are associated with several skeletal disorders. These mutations can either activate or inhibit the receptor's function. For example, gain-of-function mutations often result in conditions like thanatophoric dysplasia, a severe skeletal disorder. In histological examinations, these mutations typically show abnormal chondrocyte morphology and defective cartilage matrix, leading to impaired bone growth and development.
